This page uses content from Wikipedia and is licensed under CC BY-SA.

Tovetumab

Tovetumab
Monoclonal antibody
Type?
SourceHuman
TargetPDGFRA
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
KEGG
Chemical and physical data
FormulaC6400H9906N1726O2002S54
Molar mass144.8 kg/mol g·mol−1

Tovetumab is an anti-PDGFRa monoclonal antibody designed for the treatment of cancer.[1] It was developed by MedImmune, and trialed for use in glioblastoma and non-small cell lung cancer. Development was discontinued in 2013.[2]

This drug was developed by MedImmune, LLC.

References